1-(3,10,11,12-TETRAMETHOXY-7,8-DIHYDRO-6H-DIBENZO-[B,D]-AZOCIN-5-YL)-ETHANONE
Compound with spectra: 1 NMR
![1-(3,10,11,12-TETRAMETHOXY-7,8-DIHYDRO-6H-DIBENZO-[B,D]-AZOCIN-5-YL)-ETHANONE](/api/compound/LeB057yn31t.png?ph=true&h=300&w=458 "1-(3,10,11,12-TETRAMETHOXY-7,8-DIHYDRO-6H-DIBENZO-[B,D]-AZOCIN-5-YL)-ETHANONE")
| SpectraBase Compound ID | LeB057yn31t |
|---|---|
| InChI | InChI=1S/C21H25NO5/c1-13(23)22-10-6-7-14-11-18(25-3)20(26-4)21(27-5)19(14)16-9-8-15(24-2)12-17(16)22/h8-9,11-12H,6-7,10H2,1-5H3 |
| InChIKey | AXVSBHCWFVEWJL-UHFFFAOYSA-N |
| Mol Weight | 371.43 g/mol |
| Molecular Formula | C21H25NO5 |
| Exact Mass | 371.173273 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
7,8-DIHYDRO-3,4,10,11,12-PENTAMETHOXYDIBENZ-[C,E]-AZOCIN-5(6H)-ONE
8,9,10-trimethoxy-1,3,4,6-tetrahydrobenzo[5,6]oxepino[3,4-d]furo[3,4-b]pyridine
RAC-METHYL-(2S)-(8-ALPHA)-3,4,5-TRIMETHOXY-4',5'-METHYLENEDIOXY-2,2'-CYCLO-9'-NORLIGNAN-9-OATE
5H-Dibenzo[a,c]cycloheptene-3-carboxylic acid, 5-amino-6,7-dihydro-9,10,11-trimethoxy-, methyl ester, (S)-
(E)-6,7-DIHYDRO-3,9,10,11-TETRAMETHOXY-5H-DIBENZO-[A,C]-CYCLOHEPTEN-5-ONE-OXIME
(S)-6,7-DIHYDRO-3,4,9,10,11-PENTAMETHOXY-5H-DIBENZO-[A,C]-CYCLOHEPTEN-5-AMINE;M-CONFORMER
9,10-Dihydro-8-[(9',10'-dihydro-7'-hydroxy-5'-methoxyphenantheren-2'-yl)oxy]-6-methoxyphenanthrene-2,5-diol
1,2,3,10,11,12-Hexamethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c]cycloocten-6-ol
SZ-M6 [(7S,8R,R-biar)-6,7,8,9-tetrahydro-1,3,13,14-tetramethoxy-7,8-dimethyl-2,7,8,12-dibenzo[a,c]cyclooctenetrtraol]
MYRICANONE-5-O-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Novel B-ring modified allocolchicinoids of the NCME series: design, synthesis, antimicrotubule activity and cytotoxicity | Bioorganic & Medicinal Chemistry | 2003 |